BioMarin Pharmaceutical Inc. (BIT:1BMRN)
Italy flag Italy · Delayed Price · Currency is EUR
50.70
-4.12 (-7.52%)
Last updated: Mar 6, 2026, 5:28 PM CET

BioMarin Pharmaceutical Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Cash & Equivalents
1,312942.84755.13724.53587.28
Upgrade
Short-Term Investments
248.93194.86318.68567.01426.6
Upgrade
Cash & Short-Term Investments
1,5611,1381,0741,2921,014
Upgrade
Cash Growth
37.17%5.95%-16.86%27.39%-4.83%
Upgrade
Receivables
908.21660.54633.7461.32373.4
Upgrade
Inventory
1,2991,2331,107894.08776.67
Upgrade
Other Current Assets
185.78201.53141.39104.52110.44
Upgrade
Total Current Assets
3,9533,2322,9562,7512,274
Upgrade
Property, Plant & Equipment
991.81,0771,1121,1141,082
Upgrade
Long-Term Investments
492.24521.24622.44370.34524.29
Upgrade
Goodwill
196.2196.2196.2196.2196.2
Upgrade
Other Intangible Assets
310.84320.98325.3338.57388.65
Upgrade
Long-Term Deferred Tax Assets
1,5091,4891,5461,5051,450
Upgrade
Other Long-Term Assets
140.76151.9483.5698.7889.2
Upgrade
Total Assets
7,5946,9896,8426,3756,005
Upgrade
Accounts Payable
312.77235.4315.51231.24199.68
Upgrade
Accrued Expenses
394.32331.27311.55293.53267.65
Upgrade
Current Portion of Long-Term Debt
--493.88--
Upgrade
Current Portion of Leases
8.697.578.7810.3810.46
Upgrade
Current Income Taxes Payable
3.6712.572.6516.211.21
Upgrade
Current Unearned Revenue
--4.620.716.96
Upgrade
Other Current Liabilities
39.620.1740.0436.8160.54
Upgrade
Total Current Liabilities
759.03606.991,177588.88546.5
Upgrade
Long-Term Debt
597.18595.14593.11,0831,079
Upgrade
Long-Term Leases
37.0131.2638.1226.5133.84
Upgrade
Other Long-Term Liabilities
113.897.5781.8173.579.69
Upgrade
Total Liabilities
1,5071,3311,8901,7721,739
Upgrade
Common Stock
0.190.190.190.190.18
Upgrade
Additional Paid-In Capital
5,9575,8025,6125,4055,192
Upgrade
Retained Earnings
154.21-194.7-621.55-789.2-930.76
Upgrade
Comprehensive Income & Other
-23.9850.43-38.65-12.734.74
Upgrade
Shareholders' Equity
6,0875,6584,9524,6034,266
Upgrade
Total Liabilities & Equity
7,5946,9896,8426,3756,005
Upgrade
Total Debt
642.87633.971,1341,1201,123
Upgrade
Net Cash (Debt)
917.74503.74-60.07171.63-109.51
Upgrade
Net Cash Growth
82.19%----
Upgrade
Net Cash Per Share
4.652.56-0.310.91-0.60
Upgrade
Filing Date Shares Outstanding
192.32190.78188.68186.53184.03
Upgrade
Total Common Shares Outstanding
192.3190.76188.6186.25183.91
Upgrade
Working Capital
3,1942,6251,7792,1631,728
Upgrade
Book Value Per Share
31.6529.6626.2524.7123.19
Upgrade
Tangible Book Value
5,5805,1414,4304,0683,681
Upgrade
Tangible Book Value Per Share
29.0226.9523.4921.8420.01
Upgrade
Land
90.7890.7890.7890.7990.42
Upgrade
Buildings
910.71892.48860.81819.1774.92
Upgrade
Machinery
818.81789.5796.61736.25688.54
Upgrade
Construction In Progress
134.9190.27100.01143.38136.74
Upgrade
Leasehold Improvements
44.0444.3758.2359.5355.28
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.